Esophageal squamous cell carcinoma (ESCC) is the most common
cancer in China, and multidrug resistance (MDR) remains one of the biggest problems in ESCC
chemotherapy. In this study, we aimed to investigate the mechanism of
Caveolin-1, an
integral membrane protein, on regulating ESCC MDR. First, immunohistochemistry was used to check the
protein expression of
Caveolin-1, MDR-related
protein of
P-glycoprotein (P-gp), and
multidrug resistance protein 1 (
MRP1) in 84 pathologically characterized ESCC tissues, matched adjacent
tumor, and adjacent normal-looking tissues. The results showed that
Caveolin-1 expression level was elevated in ESCC tissues than that of matched adjacent
tumor and adjacent normal-looking tissues (P < 0.05), and the expression of
Caveolin-1 has close correlation with P-gp and
MRP1 during
tumor genesis of ESCC (P = 0.034, P = 0.009, respectively). Then,
Caveolin-1 overexpression and knockdown were used to investigate its effect on expressions of P-gp and
MRP1 in ESCC cell line Ec9706. The
messenger RNA (
mRNA) and
protein expression levels of P-gp and
MRP1 were checked by real-time quantitative reverse transcription-PCR (qRT-PCR) and Western blot (WB). The results showed that
Caveolin-1 overexpression significantly promotes the
mRNA and
protein expression of
MRP1 (P < 0.05), while almost has no effect on the
mRNA and
protein expression of P-gp (P > 0.05); Cavoelin-1 knockdown inhibits the
mRNA and
protein expressions of both P-gp and
MRP1 (P < 0.05). The similar result was found in another ESCC cell line Eca109. So, it is concluded that
Caveolin-1 affects ESCC MDR by regulating the expressions of P-gp and
MRP1; therefore, it can be taken as a significant marker and target in
tumor therapy.